Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00031024
DRKS00031024
Recruiting
未知

Optimization of polypharmacy in geriatric oncology - OPTIMA

Deutsches Krebsforschungszentrum0 sites514 target enrollmentFebruary 13, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMalignant neoplasm of bronchus and lungC15-C26C50C51-C58C81-C96C33C34C43C61C64C67Malignant neoplasms of digestive organsMalignant neoplasm of breastMalignant neoplasms of female genital organsMalignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissueMalignant neoplasm of tracheaMalignant melanoma of skinMalignant neoplasm of prostateMalignant neoplasm of kidney, except renal pelvisMalignant neoplasm of bladder

Overview

Phase
未知
Intervention
Not specified
Conditions
Malignant neoplasm of bronchus and lung
Sponsor
Deutsches Krebsforschungszentrum
Enrollment
514
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Deutsches Krebsforschungszentrum

Eligibility Criteria

Inclusion Criteria

  • •Diagnosis or recurrence requiring treatment of one of 22 frequent cancers (see chapter „Health condition for complete list) in last 5 years
  • •Exposure to polypharmacy, defined as \= 5 chronically, concurrently used active substances
  • •At least 3 weeks of in\-patient rehabilitation in a cooperating clinic are planned
  • •Sufficient capabilities for informed consent

Exclusion Criteria

  • •No written informed consent to participate
  • •No sufficient mental and physical capabilities to fill self\-administered questionnaires.
  • •No sufficient knowledge of the German language.
  • •Missing information needed to conduct the medication review with the FORTA list
  • •No medication related problem at baseline (FORTA score \= 0\).
  • •Missing baseline information needed for the primary endpoint (global quality of life).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Optimising polypharmacotherapy in geriatric patients with the medication review software MedinspectorPolypharmacy in elderly patientsAppropriateness of medicationMedication therapy safety
DRKS00027410Viandar GmbH148
Completed
Not Applicable
Optimized drug supply for geriatric patients in need of careOptimized drug supply for patients in need of care
DRKS00023757AOK Nordost – Die Gesundheitskasse1,556
Not yet recruiting
Phase 3
A study to prevent cognitive impairment (Memory related )among older Indian patients with cancer receiving chemotherapy
CTRI/2023/12/060849Tata Memorial Hospital
Withdrawn
Not Applicable
Rationalisation of Polypharmacy by the RASP-instrument and Discharge Counselling of Geriatric InpatientsPolypharmacy
NCT05816967Universitaire Ziekenhuizen KU Leuven
Completed
Not Applicable
Rationalisation of Polypharmacy by the Geriatric Consultation TeamIatrogenic Disease
NCT02165618Universitaire Ziekenhuizen KU Leuven60